Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicentre randomized open-label trial of Trinomia polypill vs separate components in cardiovascular disease
2017-002343-14Phase 3Completed
- Sponsor
- Ferrer
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin + atorvastatin + ramipril in atherothrombosis and cardiac morbidity (2 arms), sponsored by Ferrer. Primary endpoints: Change in systolic blood pressure and Change in LDL cholesterol (LDLc). Started Oct 2017; status: completed.
02
Drugs
aspirin + atorvastatin + ramipril
03
Conditions
atherothrombosiscardiac morbidity
Beyond the preview
Go deeper on 2017-002343-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002343-14.